• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:陈奋,杨月,张玲,潘卫三.基于透明质酸的纳米递药系统在肿瘤靶向治疗中的研究进展[J].中国现代应用药学,2019,36(13):1704-1710.
CHEN Fen,YANG Yue,ZHANG Ling,PAN Weisan.Research Progress of Hyaluronic Acid-based Nanodrug Delivery Systems in Targeted Cancer Therapy[J].Chin J Mod Appl Pharm(中国现代应用药学),2019,36(13):1704-1710.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2429次   下载 3532 本文二维码信息
码上扫一扫!
分享到: 微信 更多
基于透明质酸的纳米递药系统在肿瘤靶向治疗中的研究进展
陈奋1, 杨月2, 张玲3, 潘卫三2
1.辽宁中医药大学中医脏象理论及应用教育部重点实验室, 沈阳 110847;2.沈阳药科大学药学院药剂系, 沈阳 110016;3.中国医科大学附属第一医院, 沈阳 110001
摘要:
近年来,透明质酸(hyaluronic acid,HA)作为一种高效的肿瘤靶向递送载体引起了人们的广泛关注。HA的优越性主要体现在其具备良好的生物相容性、生物可降解性和特殊的CD44受体结合能力。本文针对HA的结构修饰、作为肿瘤特异性药物载体的基础理论以及基于HA纳米递药系统的研究成果进行了综述,并展望了其应用前景。
关键词:  透明质酸  肿瘤靶向递送载体  结构修饰  纳米递药系统
DOI:10.13748/j.cnki.issn1007-7693.2019.13.022
分类号:R94
基金项目:国家自然科学基金青年项目(81703709,81703425);辽宁省科技厅博士科研启动基金项目(201601186);中国博士后科学基金资助项目(2018M641716)
Research Progress of Hyaluronic Acid-based Nanodrug Delivery Systems in Targeted Cancer Therapy
CHEN Fen1, YANG Yue2, ZHANG Ling3, PAN Weisan2
1.Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China;2.Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China;3.The First Affiliated Hospital of China Medical University, Shenyang 110001, China
Abstract:
Hyaluronic acid(HA) has coming before the public in recent years for its potential application as an efficient tumor-targeting delivery vehicle. The superiority of HA is reflected as its great biocompatibility, biodegradability and special binding ability to CD44 receptor. Thus, in this review, the discussion is focused on the structural modification of HA, the rationale for the use of HA as tumor-specific carrier for drug delivery and research achievements in the field of HA-based nanodrug delivery systems. In addition, the application prospect of HA is prospected.
Key words:  hyaluronic acid  tumor-targeting delivery vehicle  structural modification  nanodrug delivery systems
扫一扫关注本刊微信